Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 1 | |
Hold | 9 | |
Sell | 1 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Rapt Therapeutics Inc have a median target of 2.00, with a high estimate of 4.00 and a low estimate of 2.00. The median estimate represents a 78.57% increase from the last price of 1.12.
High | 257.1% | 4.00 |
Med | 78.6% | 2.00 |
Low | 78.6% | 2.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 05, 2025.
Average growth rate | +11.90% |
Average growth rate | +10.45% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | -61.44% |
More ▼